» Articles » PMID: 9112592

Subcortical Type Cognitive Impairment in Herpes Zoster Encephalitis

Overview
Journal J Neurol
Specialty Neurology
Date 1997 Apr 1
PMID 9112592
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Nine immunocompetent patients with acute herpes zoster encephalitis (HZE) were studied with the help of neurological investigations. All patients were treated with acyclovir. Neuropsychological performance was compared with that of a group of 16 healthy controls. Computed tomography of the head showed infarct-like hypodense lesions in two patients, involving the internal capsule in one case and the temporoparietal cortex and white matter in another. Hypoperfusion shown by single photon emission computed tomography, mostly involving the frontal areas bilaterally, was seen in six of the seven patients examined. Hyperperfusion as seen in herpes simplex encephalitis was not encountered. One patient remained mildly demented, but all the other patients recovered relatively well. Neuropsychological examination after acyclovir treatment showed a decline in memory and speed of cognitive processes, without circumscribed neuropsychological deficits. Six of the nine patients showed behavioural disinhibition, and mood changes were also observed. Memory impairment in HZE was not as global or as severe as is described after encephalitis due to herpes simplex virus. In HZE both the brain perfusion pattern and the neuropsychological test profile showed features compatible with subcortical dysfunction.

Citing Articles

Outcome and Sequelae of Infectious Encephalitis.

Kvam K, Stahl J, Chow F, Soldatos A, Tattevin P, Sejvar J J Clin Neurol. 2024; 20(1):23-36.

PMID: 38179629 PMC: 10782093. DOI: 10.3988/jcn.2023.0240.


The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology.

Anwar M Ibrain. 2023; 9(1):63-71.

PMID: 37786515 PMC: 10529198. DOI: 10.1002/ibra.12090.


Parkinson's Disease, SARS-CoV-2, and Frailty: Is There a Vicious Cycle Related to Hypovitaminosis D?.

Palermo S, Stanziano M, Nigri A, Civilotti C, Celeghin A Brain Sci. 2023; 13(4).

PMID: 37190492 PMC: 10137159. DOI: 10.3390/brainsci13040528.


Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort.

Lophatananon A, Mekli K, Cant R, Burns A, Dobson C, Itzhaki R BMJ Open. 2021; 11(10):e045871.

PMID: 34625411 PMC: 8504358. DOI: 10.1136/bmjopen-2020-045871.


Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19.

She Q, Chen B, Liu W, Li M, Zhao W, Wu J Front Med (Lausanne). 2021; 8:694367.

PMID: 34295914 PMC: 8290059. DOI: 10.3389/fmed.2021.694367.


References
1.
Damasio A, Van Hoesen G . The limbic system and the localisation of herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 1985; 48(4):297-301. PMC: 1028292. DOI: 10.1136/jnnp.48.4.297. View

2.
Horten B, Price R, Jimenez D . Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol. 1981; 9(3):251-66. DOI: 10.1002/ana.410090308. View

3.
Whyte M, Ind P . Effectiveness of intravenous acyclovir in immunocompetent patient with herpes zoster encephalitis. Br Med J (Clin Res Ed). 1986; 293(6561):1536-7. PMC: 1342310. DOI: 10.1136/bmj.293.6561.1536. View

4.
Nauta W . The problem of the frontal lobe: a reinterpretation. J Psychiatr Res. 1971; 8(3):167-87. DOI: 10.1016/0022-3956(71)90017-3. View

5.
NORRIS Jr F, Leonards R, Calanchini P, Calder C . Herpes-zoster meningoencephalitis. J Infect Dis. 1970; 122(4):335-8. DOI: 10.1093/infdis/122.4.335. View